Introduction
Research on nickel carcinogenesis prior to 1975 has been comprehensively reviewed and critically evaluated by panels of scientific experts under the auspices of the U.S. National Academy of Sciences (NAS) (1) and the International Agency for Research on Cancer (IARC) (2) . Both scientific panels concluded that increased incidences of lung cancer and nasal cancer have been demonstrated by epidemiological studies of nickel refinery workers, and that the carcinogenicity of certain nickel compounds has been definitely established by animal experiments (1, 2) . In 1977, the U.S. National Institute of Occupational Safety and Health (NIOSH) stated that "An excess number of deaths from lung cancer and nasal cancer has been observed in nickel refinery workers. After review of the relevant data, it was concluded that a substantial portion of those excess deaths was caused by exposure to airborne nickel compounds" (3) . Readers are referred to the NAS, IARC, and NIOSH monographs (1) (2) (3) and to several review articles (4) (5) (6) (7) (8) (9) 
Epidemiological Studies
Several recent studies have analyzed the risks of respiratory tract cancers in workmen who have been exposed to inhalation of nickel compounds (10) (11) (12) (13) (14) (15) . Doll et al. (10) reinvestigated the causes of death of employees at a nickel refinery in Clydach, Wales, U.K. based upon a cohort of 967 men who began working before 1945. As shown in Table 1 (12) studied the characteristics of lung cancers in workmen at the same nickel refinery in Kristiansand, Norway. A tabulation of 39 lung cancers included 26 epidermoid (squamous cell) carcinomas, 6 small cell anaplastic carcinomas, and 7 adenocarcinomas (including related histological types). Based upon detailed analyses of work chronologies and smoking histories, Kreyberg (11) concluded that tobacco smoking contributed to the development of lung cancers in the nickel-exposed workers. Lessard et al. (13) 11 of the 12 subjects with respiratory tract cancers were smokers and that the remaining subject was a former smoker (16) . Barton (17) summarized the results of a cancer (19, 20) . * Increased nickel concentrations were found in nasal biopsy specimens from all categories of nickel-exposed workers, but the highest concentrations were found in workers from the roasting-smelting department (21) . Analyses of nickel concentrations in nasal biopsy specimens from pensioned workers showed that accumulated nickel was retained for several years after termination of nickel exposure, and was slowly released from the nasal mucosa with an estimated half-life of 3.5 years (21) . Attempts to identify the cellular localization of nickel in nasal biopsy specimens by histochemical staining methods and by energy dis-*In view of the propensity of wood-workers to develop nasal cancer, it is noteworthy that the control subject with epithelial dysplasia was a carpenter.
August 1981 persive x-ray microanalysis were inconclusive, owing to insufficient analytical sensitivity (22, 23) . Sunderman (24) reported an unusual case of polypoid squamous cell carcinoma of the nose in a 36-year-old man. The patient had worked in a cutlery factory for 12 years. For several years, he had immersed small nickel-plated objects (such as teapots) in a tank of HCI-HNO3 at 85°C in order to remove old nickel plating (e.g., from battered hotel utensils). During this operation, the patient had chronically inhaled nickel-containing acid fumes from the nickel-stripping tank. In view of the patient's relative youth and occupational history, Sundernan (24) suspected that the patient's nasal cancer was caused by nickel. Bourasset and Galland (25) previously reported a similar case of nasal cancer in a cutlery worker who had been exposed to inhalation of nickel-containing fumes.
Carcinogenicity Tests in Animals
In order to bring up to date the IARC monograph on nickel and nickel compounds (2) , this resume of recent tests of the carcinogenicity of nickel compounds in experimental animals is patterned on the IARC format.
Inhalation and/or Intratracheal Administration
Saknyn and Blohkin (20) exposed nonpedigree albino rats to inhalation of feinstein dust (an intermediate product of nickel refining, which contains NiS, NiO, and metallic Ni) in atmospheric concentration of 70 mg dust/m3 for 5 hr/day, 5 days/week during 6 months. Lung cancers (squamous cell carcinomas) were found in 2 of 5 rats that survived the treatment. The latent period for tumor development was 17 months. Saknyn and Blohkin (20) Mukubo (27) treated female albino rats by a single intratracheal injection of metallic nickel dust (10 mg/rat), alone, or in combination with methylcholanthrene (5 mg/rat). At 12 weeks, lung cancers (squamous cell carcinomas) were seen in (a) 3 of 5 rats that received nickel plus methylcholanthrene; (b) 2 of 7 rats that received methylcholanthrene alone, and (c) 0 of 7 rats that received nickel alone. The failure to detect lung cancers in the nickeltreated group should not be considered a negativecarcinogenicity test, owing to the short period of observation.
Yarita and Nettesheim (28) studied the carcinogenicity of nickel subsulfide (a-Ni3S2) in heterotopic tracheas that were transplanted (two tracheas/rat) under the dorsal skin of isogeneic female rats of the Fischer strain. Gelatin pellets were inserted into the transplanted tracheas at 4 weeks after grafting. Sixty tracheas received pellets that contained 1 mg of a-Ni3S2; 64 tracheas received pellets that contained 3 mg of a-Ni3S2, and 10 control pellets received gelatin pellets, alone. Surviving rats were killed after 20 months. At the 1 mg dose of a-Ni3S2, tumors developed in 9/60 tracheas (5 squamous cell carcinomas, 1 undifferentiated carcinoma, 2 fibrosarcomas, and 1 leiomyosarcoma). At the 3 mg dose of a-Ni3S2, tumors developed in 45/64 tracheas (1 squamous cell carcinoma, 12 fibrosarcomas, 10 leiomyosarcomas, 10 fibromyosarcomas, 2 rhabdomyosarcomas, 2 fibromyxosarcomas, 7 sarcomas of uncertain type, and 1 benign myoma). No tumors developed in the 10 control tracheas.
Oral Administration
Sunderman et al. (29) painted a-Ni3S2 in glycerol onto the buccal pouch mucosa of four groups of Syrian golden hamsters of the LVG/LAK strain. The dosage schedules were: (a) 1 mg a-Ni3S2, 3 times/week for 18 weeks in 6 hamsters; (b) 2 mg a-Ni3S2, 3 times/week for 18 weeks in 7 hamsters; (c) 5 mg a-Ni3S2, 3 times/week for 36 weeks in 15 hamsters; and (d) 10 mg a-Ni3S2, 3 times/week for 36 weeks in 13 hamsters. Surviving hamsters were killed at 24 months after the initial application. No tumors were found in the buccal pouch, oral cavity or gastrointestinal tract of any of these hamsters, or in 15 controls that received buccal pouch applications of the glycerol vehicle (0.2 ml, 3 times/week for 36 weeks). Cancers (squamous cell carcinomas) of the buccal pouch were found in 4/4 hamsters in a positive control group that received similar applications of dimethylbenzanthracene in glycerol (1 mg DMBA, 3 times/week for 18 weeks).
Intramuscular Injection
Sunderman (30) administered a-Ni3S2 to albino mice of both sexes by a single IM injection (2.5 mg a-Ni3S2/mouse). Within 100 weeks, sarcomas developed at the injection site in 6/9 mice of the DBA-2 strain (versus 0/9 vehicle controls) and in 5/10 mice of the C57-BL6 strain (versus 0/9 vehicle controls).
Sunderman et al. (31) gave single IM injections of six nickel compounds in equal doses (14 mg Ni/rat) to male Fischer rats. This experiment was a 134 supplement to an earlier study (32) that was included in the 1976 IARC monograph (2) . By 100 weeks after the IM injection, the incidences of sarcomas at the injection sites were: (a) metallic Ni dust: 13/20 rats; (b) crystalline nickel subselenide (Ni3Se2): 21/23 rats; (c) crystalline nickel monoselenide (NiSe): 8/16 rats; (d) crystalline nickel subsulfide (ot-Ni3S2): 9/9 rats; (e) crystalline nickel monosulfide (,-NiS): 14/14 rats; (f) amorphous nickel monosulfide (NiS): 0/10 rats; and (g) vehicle controls: 0/44 rats. Based upon the marked differences in sarcoma incidences after an IM injection of crystalline P-NiS and amorphous NiS, Sunderman et al. (31) concluded that the physical form of nickel sulfides has a critical influence upon their carcinogenic activities. In the same experiment, sarcomas were observed at the injection site in 3/16 rats that received a lower dose (7 mg Ni/rat) of nickel carbonylcyclopentadiene dimer; [Ni(CO)2(C5H5)2]2.
Sunderman (30) derived a dose-response curve for induction of sarcomas in male Fischer rats by single IM injection of ot-Ni3S2, based upon four published and two previously unpublished experiments which involved a total of 383 rats. The experiments were all terminated at 100 to 104 weeks after the injection. Sarcoma incidence at 62 weeks after the injection was linearly related to the reciprocal of the o-Ni3S2 dose, and ranged from 24% (7/29) in rats that received 0.63 mg of a-Ni3S2, to 100% (9/9) in rats that received 20 mg of a-Ni3S2. There was no indication of a threshold carcinogenic dosage in this experimental system. The histologic types of 336 sarcomas induced by an IM injection of a-Ni3S2 included 161 rhabdomyosarcomas, 91 undifferentiated sarcomas, 72 fibrosarcomas, 9 liposarcomas, 2 neurofibrosarcomas, and 1 hemangiosarcoma. Metastases were found in 41% (137/336) of tumor-bearing rats.
Sunderman et al. (33) gave male Fischer rats a single IM injection of a-Ni3S2 (1.2 mg/rat), alone, or in combination with metallic Mn dust (1.0 mg/rat) or metallic Cr dust (1.0 mg/rat). Within 100 weeks, the sarcoma incidence in rats that received only a-Ni3S2 was 22/30. Addition of Mn dust to a-Ni3S2 reduced the sarcoma incidence to 1/14, whereas addition of Cr dust to a-Ni3S2 did not affect the sarcoma incidence (12/15) . No sarcomas developed at the IM injection site in three control groups, including 39 rats that received the injection vehicle, 14 rats that received Mn dust alone (1.0 mg/rat), and 15 rats that received Cr dust alone (1.0 mg/rat).
Sunderman (29) 6 male), and 7/11 Wistar-Lewis rats (6 female, 5 male). In contrast, no renal tumors developed in 12 a-Ni3S2-treated Long-Evans rats (6 female, 6 male). In male Fischer rats that received an IR injection of a-Ni3S2 (10 mg/rat) combined with metallic Mn dust (7 mg/rat), the incidence of renal tumors was 17/28, which differed significantly from the corresponding incidences of 18/24 and 0/23 in male Fischer rats that received IR injections of a-Ni3S2 (10 mg/rat) alone or Mn dust (7 mg/rat) alone. The 54 renal tumors that were observed by Sunderman et al. (40) in a-Ni3S2-treated rats were all malignant, and metastases were found in 37/54 tumor-bearing rats. The authors were uncertain whether the renal cancers were epithelial or mesenchymal in origin (40) . In three a-Ni3S2-treated rats, the injected eye had two primary tumors, and in two a-Ni3S2-treated rats, the injected eye had three distinct primary tumors. The 22 ocular neoplasms included 11 amelanotic uveal melanomas, 4 
Intratesticular Injection

Relevant Experiments in Animals X-Ray Diffractometry and Radiotracer Studies
The metabolism of a-Ni3S2 in rodents has been investigated by x-ray diffractometry (44, 45) and by radiotracer studies (33, (44) (45) (46) 'S from the injection site. There was also mobilization of nonsolubilized 'Ni-labeled particles, which were located within phagocytes in liver, spleen, and regional lymph nodes (45) . These in vivo findings are compatible with earlier observations of Kasprzak Environmental Health Perspectives and Sunderman (44) , who employed x-ray diffractometry to elucidate the dissolution of a-Ni3S2 during in vitro incubation in rat serum. a-Ni3S2 was slowly oxidized to crystalline nickel monosulfide (,3-NiS), which subsequently underwent further oxidation to yield soluble Ni(II) complexes and relatively insoluble particles of nickel hydroxide [Ni(OH)2] (44).
Electron Microscopic Studies
Bruni (48) administered a-Ni3S2 to male Sprague-Dawley rats by unilateral or bilateral IM injection into the thigh muscles (20 mg/injection). The rats were sacrificed at intervals from 2 to 26 weeks, and tissue from the injection site was examined by electron microscopy. Mitotic activity was seen primarily in muscle satellite cells. Satellite cells in division were morphologically indistinguishable from dividing stem cells in a-Ni3S2-induced rhabdomyosarcomas. On the basis of these findings, Bruni (48) suggested that muscle satellite cells are progenitors of the a-Ni3S2-induced tumors.
Hildebrand and Biserte (49) performed electron microscopy of 12 rhabdomyosarcomas that were induced in an unspecified number of Wistar rats by IM implantation of a-Ni3S2 in agar (20 mg aNi3S2/rat). Successive stages of differentiation of tumor cells were described, and formation of microtubules in interphase rhabdomyoblasts was convincingly demonstrated. Hildebrand and Biserte (49) did not -observe any satellite cells in the rhabdomyosarcomas. In another study, Hildebrand and Biserte (35) described cylindrical paracrystalline structures in rhabdomyoblasts ofrhabdomyosarcomas that were induced in rabbits by IM injection of a-Ni3S2 in agar (80 mg a-Ni3S2/rabbit). The authors speculated that the laminated cylindrical bodies represented abnormal aggregates of contractile proteins that were synthesized during myofibrillar differentiation.
Jasmin et al. (50) treated 25 female SpragueDawley rats by IR injection of a-Ni3S2 in glycerol (5 mg a-Ni3S2/rat). Groups of five rats were killed at biweekly intervals until 2 months, and the injected kidneys were examined by electron microscopy. Unusual crystalline inclusions were observed in mitochondria of tubular cells that were located in the pars recta of the distal nephron. By goniometric analysis, the authors deduced that the crystalline inclusions were composed of cylindrical rods in a hexagonal array. Jasmin et al. (50) speculated that the crystalline inclusions might consist of abnormal assemblages of protein components of mitochondrial cristae. August 1981 Cytogenetic and Tumor Transplantation Studies Yamashiro et al. (51) performed karyotypic analyses and transplantation experiments on rhabdomyosarcomas that were induced in Fischer and Long-Evans rats by single IM injection of a-Ni3S2 (10 mg/rat). The chromosomal complements oftumor cells from 12 primary rhabdomyosarcomas were usually in the diploid range, although 11 of the 12 tumors contained a few triploid and tetraploid cells. Abnormal chromosomes were found, including dicentric, triradial, and ring forms. Comparisons of chromosomes of primary and metastatic tumor cells suggested that tumors with diploid or near-diploid chromosomes were most likely to metastasize. Rhabdomyosarcoma cells were cultured in vivo in diffusion chambers which were implanted in the peritoneal cavity of syngeneic rats. Such cell cultures exhibited less myogenic differentiation than parallel cell cultures which were incubated in vitro in Leighton tubes (51) .
Abandowitz (52) added neuraminidase to cultured cells from an a-Ni3S2-induced rat fibrosarcoma. The neuraminidase treatment inhibited tumor growth following inoculation of the fibroblasts into normal recipient rats. The recipient rats acquired enhanced resistance to subsequent inoculations of tumor cells.
Effects on DNA Synthesis in Vivo Hui and Sunderman (53) 
Relevant Studies in Cell Cultures
In vitro exposure of mammalian cells to certain nickel compounds inhibits cellular uptake of thymidine-3H and induces chromosomal aberrations, somatic mutations, and morphological transformation. In studies which were briefly mentioned in the NAS and IARC monographs (1, 2), Basrur and Gilman (56) and Swierenga and Basrur (57) showed that addition of a-Ni3S2 to cultures of rat embryo muscle cells profoundly inhibited thymidine-3H uptake, suppressed cell division, and induced bizarre mitoses, including multipolar and distorted bipolar spindles, C-metaphase-like shapes, and lagging chromosomes. Mitotic arrest occurred in telophase and post-telophase, consistent with disturbed dissolution ofmitotic spindles. In a recent study, Nishimura and Umeda (58) found that addition of nickel compounds, (NiC12, NiS, nickel acetate, and potassium cyanonickelate), to cultures ofmouse mammary carcinoma cells inhibited thymidine-3H uptake and increased the frequency of chromosomal aberrations. Anacher and Paillet (59) (67) suggested that the striking disparity in carcinogenic activity of crystalline a-Ni3S2 and amorphous NiS may be attributed to marked differences in cellular uptake of the two compounds.
Rivedal and Sanner (68) employed in vitro morphological transformation and induction of somatic mutation to investigate synergism between nickel and polycyclic aromatic hydrocarbons. The transformation frequency of Syrian hamster embryo cells increased with increasing concentrations of NiSO4, benzo(a)pyrene (BP), or methylcholanthrene (MC). When cells were exposed to combinations of NiSO4 and BP, the transformation frequencies were much higher than when the compounds were tested separately. The greatest enhancement was found with 5 ,ug/ml ofNiSO4-6H20 and 0.78 jig/ml of BP. The transformation frequency obtained with this combination was 10.7%, compared to frequencies of 0.5% and 0.6% that were obtained with the individual substances. No synergistic effect was detected between NiSO4 and MC. In experiments that measured somatic mutations in Syrian hamster embryo cells by selection for ouabain-resistance, the mutation frequency was significantly higher than expected when the cells were exposed to mixtures of NiSO4 and BP (68) . Rivedal and Sanner's observation of mutagenic synergism between NiSO4 and BP is consistent with an earlier report by Maenza et al. (69) of carcinogenic synergism between a-Ni3S2 and BP following IM injection in Fischer rats. Sunderman (70) observed that exposure of rats to Ni(CO)4 by inhalation or IV injection inhibited phenothiazine induction of BP (arylhydrocarbon) hydroxylase activity in lung and liver. Sunderman and Roszel (71) administered BP to rats by IV injection and studied the effect of Ni(CO)4 on the retention of BP in lung and liver. A single exposure of rats to Ni(CO)4 inhibited BP mobilization from lung and liver for 48 hr (70) . The inhibitory effects of nickel compounds on BP metabolism are of especial interest in view of the potentiating effect of cigarette smoking on the development of lung cancer in nickel refinery workers (12, 13, 16) .
Mutagenicity Tests in Bacteria
Bacterial mutagenesis tests of nickel compounds have consistently been negative, despite several attempts by experienced workers to demonstrate Environmental Health Perspectives mutagenicity in E. coli or S. typhimurium (7, (72) (73) (74) (75) (79) found that Ni(II) increased misincorporation of deoxynucleotides by E. coli DNA polymerase I during transcription of synthetic polynucleotide templates. Loeb et al. (80) and Zakour et al. (81) speculated that carcinogenic metals may diminish the fidelity of DNA polymerase activity in target cells in vivo, and may thereby induce errors in selection of nucleotide bases during DNA synthesis. According to this hypothesis, decreased fidelity of DNA polymerase might initiate a cascade of random somatic mutations and evolve transformed cells that possess selective advantages for proliferation in the host. This hypothesis and related theories about possible molecular mechanisms of metal carcinogenesis have been considered in recent review articles (7, 75, 81, 82) .
Prospects for Future Research
The demonstration by Sirover and Loeb (80) 26, 1977) . Dr. Goran Lofroth (University of California, Berkeley, CA) also obtained negative results in the Ames mutagenesis test system with a-Ni3S2, (personal communication on March 3, 1977) . advantageous compound for use in such studies, since a-Ni3S2 is inexpensively available in high purity and is readily labelled with 63Ni, a betaemitting radioisotope with long half-life that is well suited for liquid scintillation counting and autoradiography. The carcinogenic activity of a-Ni3S2 is apparently greater than any other metallic compound which has been investigated (6) . A remarkable variety ofanimal species, routes ofadministration and cell culture systems can be employed for cancer research with a-Ni3S2. Furthermore, neoplastic transformation by a-Ni3S2 can be suppressed by manganese dust in vivo and in vitro (30, 33, 40, 64) . This observation may serve as a clue to identify the biochemical effects of a-Ni3S2 that are specifically associated with neoplastic transformation.
